Angiotensin II, TGF-beta and renal fibrosis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Contributions to Nephrology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11705280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction.

  2000cited by this paper
• Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats.

  2000cited by this paper
• Fibrosis and hypertensive heart disease

  2000cited by this paper
• Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney.

  2000cited by this paper
• Role of transforming growth factor-beta1 in cardiovascular inflammatory changes induced by chronic inhibition of nitric oxide synthesis.

  2000cited by this paper
• Transforming Growth Factor &bgr; in Hypertensives With Cardiorenal Damage

  2000cited by this paper
• Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

  2000cited by this paper
• Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.

  2000cited by this paper
• High Plasma Concentrations Of Prorenin In A Transgenic Animal Model Of Nephropathy With Overexpression Of Transforming Growth Factor‐β1 In The Kidneys

  2000cited by this paper
• Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.

  2000cited by this paper
• Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor‐β2

  1999cited by this paper
• Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients.

  1999cited by this paper
• Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.

  1999cited by this paper
• Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis.

  1999cited by this paper
• Decorin attenuates gliotic scar formation in the rat cerebral hemisphere.

  1999cited by this paper
• Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice.

  1999cited by this paper
• Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice.

  1999cited by this paper
• Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade.

  1998cited by this paper
• Glomerular endothelial cells synthesize collagens but little gelatinase A and B.

  1998cited by this paper
• Physiologic Actions and Molecular Expression of the Renin-Angiotensin System in the Diabetic Rat

  1998cited by this paper
• Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells.

  1997cited by this paper
• Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.

  1997cited by this paper
• Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

  1997cited by this paper
• Increased Renal Production of Transforming Growth Factor-β1 in Patients with Type II Diabetes

  1997cited by this paper
• Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts.

  1997cited by this paper
• Transforming growth factor beta mediates the angiotensin-II-induced stimulation of collagen type IV synthesis in cultured murine proximal tubular cells.

  1996cited by this paper
• Transforming growth factor-beta modulation of the alpha 1(IV) collagen gene in murine proximal tubular cells.

  1996cited by this paper
• Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.

  1996cited by this paper
• Expression of transforming growth factor-beta isoforms in human glomerular diseases.

  1996cited by this paper
• Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.

  1995cited by this paper
• Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney.

  1995cited by this paper
• Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts.

  1995cited by this paper
• Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

  1994cited by this paper
• Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

  1993cited by this paper
• Transforming growth factor-beta is a renin secretagogue at picomolar concentrations.

  1993cited by this paper
• Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.

  1993cited by this paper
• Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

  1992cited by this paper
• Transforming growth factor-beta in disease: the dark side of tissue repair.

  1992cited by this paper
• Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.

  1990cited by this paper
• Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

  1990cited by this paper

• Combining experiments and bioinformatics to identify transforming growth factor-β1 as a key regulator in angiotensin II-induced trophoblast senescence.

  2024cites this paper
• Radiation Induced Skin Fibrosis (RISF): Opportunity for Angiotensin II-Dependent Intervention

  2024cites this paper
• Necessity and choice of therapy for Henoch-Schönlein purpura nephritis.

  2022cites this paper
• Hormonal Regulation of Renal Fibrosis

  2022cites this paper
• Use of Platelet-Rich Plasma Plus Suramin, an Antifibrotic Agent, to Improve Muscle Healing After Injuries

  2021cites this paper
• A review on the efficacy and mechanism of action of Shenkang injection against chronic kidney disease.

  2020cites this paper
• Losartan accelerates the repair process of renal fibrosis in UUO mouse after the surgical recanalization by upregulating the expression of Tregs

  2019cites this paper
• Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis

  2016cites this paper
• Promising therapies for treatment of nonalcoholic steatohepatitis

  2016cites this paper
• Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1-Smad3 signaling pathway.

  2015cites this paper
• Effect of Shenkang granules on the progression of chronic renal failure in 5/6 nephrectomized rats.

  2015cites this paper
• Differentiating Glomerular Inflammation from Fibrosis in a Bone Marrow Chimera for Rat Anti-Glomerular Basement Membrane Glomerulonephritis

  2015cites this paper
• RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species.

  2014cites this paper
• Targeting reduction of proteinuria in glomerulonephritis: Maximizing the antifibrotic effect of valsartan by protecting podocytes

  2014cites this paper
• Grape seed extract attenuates arsenic-induced nephrotoxicity in rats

  2013cites this paper
• A nonclassical vitamin D receptor pathway suppresses renal fibrosis.

  2013cites this paper
• Olmesartan for non-alcoholic steatohepatitis complicated with hypertension: An open-label study *

  2013cites this paper
• Reduction of osteopontin in vivo inhibits tubular epithelial to mesenchymal transition in rats with chronic allograft nephropathy.

  2013cites this paper
• Molecular Mechanisms of Nephro-Protective Action of HE-86 Liquid Extract in Experimental Chronic Renal Failure

  2012cites this paper
• The effects of rheum officinale on the progression of feline chronic kidney disease.

  2011cites this paper
• Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial

  2011cites this paper
• Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease

  2011cites this paper
• Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis.

  2011cites this paper
• Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells

  2011cites this paper
• Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.

  2011cites this paper
• Investigación de nuevas estrategias terapeúticas para la inflamación y la fibrosis hepática.

  2010cites this paper
• Blockade of Osteopontin Inhibits Glomerular Fibrosis in a Model of Anti-Glomerular Basement Membrane Glomerulonephritis

  2010cites this paper
• Reduction of advanced liver fibrosis by short‐term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats

  2010cites this paper
• Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis.

  2010cites this paper
• NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.

  2010cites this paper
• Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population.

  2009cites this paper
• Nephro-protective effect of Kangqianling decoction on chronic renal failure rats.

  2009cites this paper
• Deletion of bradykinin B1 receptor reduces renal fibrosis.

  2009cites this paper
• Upregulation and function of GADD45gamma in unilateral ureteral obstruction.

  2008cites this paper
• HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease.

  2008cites this paper
• Cytokines and renin-angiotensin system signaling in hepatic fibrosis.

  2008cites this paper
• Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.

  2008cites this paper
• Effects of tanshinone IIA on transforming growth factor β1-Smads signal pathway in renal interstitial fibroblasts of rats

  2008cites this paper
• Emerging drugs for complications of end-stage liver disease

  2008cites this paper
• Angiotensin II activates plasminogen activator inhibitor-I promoter in renal tubular epithelial cells via the AT1 receptor.

  2007cites this paper
• Administration of poly-D-glutamic acid induces proliferation of erythropoietin-producing peritubular cells in rat kidney.

  2007cites this paper
• Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

  2007cites this paper
• Mechanisms of progression of chronic kidney disease

  2007influential citation
• Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C

  2007cites this paper
• Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.

  2007cites this paper
• Primary hypertension and nephropathy.

  2006cites this paper
• Antifibrotic Agents for Liver Disease

  2006influential citation
• Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis.

  2006cites this paper
• Pharmacological management of renal fibrotic disease

  2006cites this paper
• Aldosterone antagonism in chronic kidney disease.

  2006cites this paper
• Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms.

  2006cites this paper
• Hochdrucktherapie und frühe Nephroprotektion

  2006cites this paper
• Transforming growth factor-beta1, Th1 responses, and autoimmune liver disease.

  2005cites this paper
• Postirradiation morphea and subcutaneous polyarteritis nodosa: case report and literature review.

  2005cites this paper
• Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

  2005cites this paper
• Differential expression of angiotensin receptors in human cutaneous wound healing

  2005cites this paper
• NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis.

  2005cites this paper
• Growth Factors, Cytokines, Cell Cycle Molecules Ultrasound-Microbubble-Mediated Gene Transfer of Inducible Smad7 Blocks Transforming Growth Factor- Signaling and Fibrosis in Rat Remnant Kidney

  2005cites this paper
• Transforming growth factor‐β1, Th1 responses, and autoimmune liver disease

  2005cites this paper
• Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.

  2005cites this paper
• Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct–ligated rats

  2005cites this paper
• Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1.

  2005cites this paper
• Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.

  2004cites this paper
• Galectin‐3/AGE‐receptor 3 knockout mice show accelerated AGE‐induced glomerular injury: evidence for a protective role of galectin‐3 as an AGE receptor

  2004cites this paper
• Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.

  2004cites this paper
• Effect of sirolimus on renal ischaemia/ reperfusion injury in normotensive and hypertensive rats

  2004cites this paper
• Metastable Tolerance to Rhesus Monkey Renal Transplants Is Correlated with Allograft TGF-β1+CD4+ T Regulatory Cell Infiltrates1

  2004cites this paper
• Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.

  2004cites this paper
• Transforming growth factor β and the immunopathologic assessment of tolerance

  2004cites this paper
• Effect of sirolimus on renal ischaemia/reperfusion injury in normotensive and hypertensive rats

  2004cites this paper
• Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells.

  2004cites this paper
• Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis.

  2004cites this paper
• Fatty acids modulate transforming growth factor-beta activity and plasma clearance.

  2003cites this paper
• Altered tubular albumin degradation in the pathogenesis of albuminuria: additional experimental evidence challenging the paradigm of glomerular capillary leakage.

  2003cites this paper
• Angiotensin-converting enzyme inhibition but not β-adrenergic blockade limits transforming growth factor-β overexpression in acute normotensive anti-thy1 glomerulonephritis

  2003cites this paper
• The role of gender in the progression of renal disease.

  2003cites this paper
• A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.

  2003cites this paper
• Tubulointerstitial disease: role of ischemia and microvascular disease

  2003cites this paper
• Mechanisms of repair after kidney injury.

  2003cites this paper
• A single pathway for the development of essential hypertension.

  2003cites this paper
• Angiotensin II and progressive renal insufficiency

  2002cites this paper